Eurofins subsidiary empowerDx today launched its PFAS Exposure direct-to-consumer at-home test in the U.S. Luxembourg-based Eurofins touts the per- and polyfluorinated alkyl substances (PFAS) test as the first direct-to-consumer, at-home test for determining the levels of PFAS in a person’s blood and measure 47 of the PFAS “forever chemical” compounds. According to a news release, […]
Eurofins
Eurofins, Rite Aid launch OTC at-home COVID-19 test in U.S.
Eurofins, its empowerDX subsidiary and Rite Aid announced the launch of an over-the-counter, at-home COVID-19 PCR test kit. Luxembourg-based Eurofins’ co-branded kits will be made available at all Rite Aid locations across 17 U.S. states, offering both symptomatic and asymptomatic users a way to test for COVID-19 at home, according to a news release. Eurofins […]
Eurofins launches COVID-19 testing network to facilitate European travel
Eurofins announced today that it opened a network of about 500 COVID-19 testing centers across Europe to help facilitate summer travel. Luxembourg-based Eurofins’ network covers major traveling hubs to provide testing accessibility in locations ranging from supermarkets to business parks and residential areas, too. According to a news release, the company’s 500-center network is already […]
Eurofins gains EUA for young children’s COVID test
Eurofins announced today that it received FDA emergency use authorization (EUA) for its at-home COVID-19 testing kit for children 3 years of age and older. Luxembourg-based Eurofins’ Clinical Enterprise subsidiary became the first to receive EUA for an at-home nasal PCR test for young children with the empowerDX kit, according to a news release. In […]
Eurofins launches SARS-CoV-2 test kit
Eurofins (Paris:ERF.PA) announced today that it launched the GSD NovaPrime SARS-CoV-2 Mplex FLA (Sanger) kit for COVID-19 testing. Luxembourg-based Eurofins’ test kit uses the fragment length analysis principle on Sanger sequencing instruments, such as the ABI 373xl, with the assay enabling each sequencer to process more than 2,000 samples per day while the kit provides sensitivity […]
DTW: Philips’ Imaged Guided leader Landon shares global giant’s plans for minimally invasive devices
In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse. In this conversation we’ll learn: Why Landon left Medtronic Where Philips fits into medtech’s future How Philips hopes to expand Will Philips […]
FDA issues EUAs for two at-home COVID-19 tests
Two companies announced today that they received FDA emergency use authorizations (EUAs) for at-home COVID-19 diagnostic tests. Eurofins (Paris:ERF.PA) and DxTerity Diagnostics each received the authorization for separate COVID-19 tests, one of which is nasal-based and the other saliva-based. Luxembourg-based Eurofins’ at-home nasal PCR test is touted as a minimally invasive and quick option that offers […]
Eurofins launches 10-minute COVID-19 exposure testing device
Eurofins (Paris:ERF.PA) announced today that it launched its rapid point-of-care testing devices to identify past exposure to COVID-19. The serology-based, finger-prick tests detect antibodies with a sensitivity of 94.5% from 19 days following the onset of symptoms, with results coming in just 10 minutes, according to a news release. Eurofins’ CE-Marked INgezim dual-recognition immunochromatographic assays […]
DeviceTalks West 2019: Medtech expertise you need to know
There was a wide variety of expertise to be had on the show floor of DeviceTalks West, held in December 2019 in Silicon Valley. Find out about materials testing standards from Eurofins, the evolving nature of contract manufacturing at Tegra Medical, improved medical device design strategies from Triple Ring Technologies, big-box builds at Valtronic, and […]
